Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Reddy's Laboratories is a leading multinational pharmaceutical company headquartered in Hyderabad, India, that provides a wide range of products and services including Active Pharmaceutical Ingredients (APIs), generics, biosimilars, and differentiated formulations. The company operates through three main business segments: Global Generics, Pharmaceutical Services & Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's has a significant global presence, with major markets in the United States, India, Russia, and Europe. In addition to its extensive generic portfolio, the company is increasingly focusing on complex generics, biosimilars, and specialty medicines to address unmet medical needs in therapeutic areas such as oncology, gastroenterology, and cardiovascular health. The company also offers contract development and manufacturing services (CDMO) through its subsidiary, Aurigene Pharmaceutical Services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reddy S.H..